Jolastic

Chlorphenamine Maleate and Paracetamol, the active ingredients in Jolastic, is a first‑generation antihistamine and analgesic/antipyretic presented as an oral tablet for oral use. It relieves nasal congestion, sneezing, itching, fever and mild to moderate pain in adults and children. GNH USA supplies Jolastic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Jolastic combines chlorphenamine maleate and paracetamol to address allergic and flu‑related symptom groups.

- Allergic rhinitis: reduces nasal congestion, sneezing and itching associated with seasonal allergies. - Common cold: alleviates headache, sore throat, fever and general discomfort. - Mild to moderate pain: provides analgesia for headache, musculoskeletal aches and sore throat.

Adverse reactions to Jolastic are generally mild but may vary among individuals.

Common Side Effects: - Drowsiness: mild sedation or sleepiness. - Dry mouth: reduced salivation. - Nausea: mild stomach upset. - Dizziness: transient light‑headedness.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling or anaphylaxis. - Hepatotoxicity: elevated liver enzymes or liver injury with excessive paracetamol exposure. - Cardiac arrhythmia: rare palpitations or irregular heartbeat.

Before using Jolastic, consider the following safety points. - Pregnancy: consult a healthcare professional; safety data are limited. - Liver disease: use with caution; paracetamol dose may need adjustment. - Asthma: chlorphenamine may exacerbate bronchospasm in susceptible individuals. - Alcohol: avoid excessive intake as it may increase liver risk. - Concomitant CNS depressants: may enhance drowsiness. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Jolastic may interact with several medicines; awareness helps avoid complications.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Other antihistamines: additive sedation. - Alcohol: increased risk of liver toxicity and CNS depression. - Warfarin: paracetamol may enhance anticoagulant effect.

Moderate Interactions (Monitor Closely): - CYP450 substrates: paracetamol may affect metabolism of certain drugs. - CNS depressants (benzodiazepines, opioids): monitor for enhanced sedation. - Anticholinergic drugs: may increase dry mouth.